|
|
|||||||||||||||||||||||
Article Navigation
|
Lycopene Effective with Prostate Cancer Treatmentby: Darin Ingels Men with prostate cancer who take supplemental lycopene in addition to surgical removal of the testicles may experience less active disease, less bone pain, and live longer than those who only have surgical removal of the testicles, according to a new study in British Journal of Urology International (2003;92:375–8). This is exciting news for millions of men who have to undergo aggressive treatment for advanced prostate cancer. Prostate cancer is the most common cancer found in men over the age of 50 years, with more than 200,000 new cases each year in the United States. The cause of prostate cancer, like many other cancers, is unknown; however, some studies suggest alterations in testosterone metabolism may play a role in its development. Prostate cancer is generally slow growing and may not cause any symptoms until late in the disease. Symptoms may include frequent or painful urination, dribbling after urination, sensation of incomplete emptying of the bladder, or blood in the urine. The symptoms of prostate cancer are similar to those of a non-cancerous condition called benign prostatic hyperplasia (BPH), so men experiencing these symptoms should consult their physician for an accurate diagnosis. In the new study, 54 men with advanced prostate cancer were randomly assigned to have surgical removal of the testicles (orchidectomy) alone or orchidectomy plus oral supplementation with 4 mg of lycopene a day. Measurements of PSA (a blood marker of prostate cancer activity), bone scans, and urinary flow were taken initially and every three months for two years. Men receiving lycopene started on the day of their surgery. After six months, PSA had significantly decreased in both groups, indicating a reduction in prostate cancer activity. However, PSA levels in those receiving lycopene were more than 65% lower than in those who did not receive lycopene. After two years, PSA levels in the lycopene treatment group had fallen into the normal range, while those who only underwent surgery still had PSA levels more than twice the upper limit of normal. Urinary symptoms significantly improved in both groups, but better improvement was again observed in the lycopene group. The lycopene group also experienced less bone pain. The survival rates after two years in the lycopene-plus-surgery group and surgery-only groups were 87% and 78%, respectively, a statistically significant difference. No adverse side effects were observed in men taking lycopene.LycopeneLycopene is one of a group of compounds called carotenoids. It is found in high amounts in tomatoes. The findings of this study corroborate the findings of other similar studies examining the effectiveness of lycopene in the treatment of prostate cancer. However, the amount used in the current study (4 mg per day) was substantially less than the amounts used in other studies (30 mg per day). It may also help stimulate the immune system and has been shown to cause cancer cells to die on their own. Although more research is needed to clarify what amount of lycopene is most effective, men with prostate cancer may benefit from taking daily lycopene supplements. Eating one moderately sized tomato a day also provides approximately 4 mg of lycopene. Other tomato products, such as an 8-ounce portion of tomato juice or tomato paste may provide up to 25 mg of lycopene. Latest Cancer News:Cancer Connection: Survivor's guilt can be painful side effect of cancer People going through cancer treatment at the same time often form their own peer group. They see each other in chemo, in radiation and in various support groups. The fortunate ones do well, but they often feel guilty when others in their cohort succumb to the disease. Cancer institute celebrates opening of expansion LITTLE ROCK ? Forty cancer survivors shared the stage with dignitaries such as Gov. Mike Beebe and former U.S. Sen. David Pryor at a ceremony today marking the opening of a 12-story expansion to the Winthrop P. Rockefeller Cancer Institute. Cancer Research UK launches new £18 million Biotherapeutics Development Unit Cancer Research UK's Drug Development Office marks the launch of its Biotherapeutics Development Unit (BDU) today (Friday) with the manufacture of its first product - an antibody for treating a range of cancers. Cancer Vaccine: 4 Months of Life Worth $100K? Prostate cancer vaccine, Provenge, adds 4 months to life, at a pricetag of 100K. The first-ever approved cancer vaccine, Provenge offers hope to men with advanced prostate cancer, but the high cost of this new treatment raises healthcare policy questions. Prostate cancer - Sipuleucel-T - Cancer - Cancer vaccine - Health CÁNCER (Julio 30) CÁNCER: No olvides desarrollar tu trabajo con organización y perseverancia. Trata de hacer algo totalmente nuevo; tus amistades serán tus mejores aliadas. Breast Cancer's DNA Yields More Secrets Title: Breast Cancer's DNA Yields More Secrets Category: Health News Created: 7/29/2010 2:10:00 PM Last Editorial Review: 7/30/2010 Cancer Group Says State Failing To Combat Disease The American Cancer Society released a statement saying Tennessee is falling short on legislative efforts to fight the disease. Cancer patients in windpipe swap op Doctors have successfully transplanted windpipes into two cancer patients in an innovative procedure that uses stem cells to allow a donated trachea to regenerate tissue and create an organ biologically close to the original. Related Stories Two killed in Los Angeles explosion Billy the Kid pardon considered Chelsea Clinton set to tie the knot Everglades added to UN danger list Wilders denied ... Cancer survivors show how to LiveStrong Oklahoma cancer patients and survivors will pitch for a future free of cancer at the annual LiveStrong Night with the Oklahoma City RedHawks. Turner Mason Swink, an Oklahoma City eighth-grader first diagnosed with cancer when he was only a year old, and 8-year-old Caitlin Schemmel, a third-grader from Colbert diagnosed with leukemia in December, will throw out the first pitch at the event ... Male Breast Cancer In Family Leads To High Perception Of Risk, Low Likelihood Of Genetic Counseling People with a family history of male breast cancer perceive themselves to be at higher risk of developing the disease than do patients with a family history of female breast cancer; however those with male breast cancer in their families are less likely to know about or seek genetic testing than those with a family history of female breast cancer, according to a study led by researchers at the ... Showtime stays true to form with 'The Big C,' a cancer comedy - Dallas Morning News
|
||||||||||||||||||||||
Copyright © 2006 CancerAdvice.org